Li Rui, Sun Xu, Yu Zhiyuan, Li Peiyu, Zhao Xudong
Medical School of Chinese PLA, Beijing, China.
Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Fuxing Road 28, Haidian District, Beijing, 100853, China.
BMC Cancer. 2025 Apr 15;25(1):700. doi: 10.1186/s12885-025-14104-0.
Colorectal cancer (CRC) is the most prevalent malignant tumor of the digestive system globally, ranking third in incidence and second in mortality. In previous studies, the rate of lymph node metastasis (LNM) in T2 CRC ranged from 18.0 to 28.0%. We aim to identify T2 CRC patients without LNM and thereby mitigate the complications and potential impact on the quality of life associated with surgery.
In this retrospective study, 787 cases with T2 CRC were selected. The preoperative and postoperative clinicopathological features were retrospectively studied. Univariate analysis and multivariate analysis were performed using binary logistic regression to determine the predictive factor for LNM. Odds ratio (OR) and 95% confidence interval (CI) were conducted.
184 (23.4%) patients were diagnosed with LNM, including 144 (78.3%) patients with N1stage and 40 (21.7%) patients with N2 stage. According to univariate analysis and multivariate analysis, poorly differentiated tumors (p = 0.003, OR = 4.405, 95%CI: 1.632-11.893), perineural invasion (p = 0.001, OR = 4.789, 95%CI: 1.958-11.716), and lymphovascular invasion (p = 0.001, OR = 2.779, 95%CI: 1.497-5.159) were independent risk factors of LNM, while male (p = 0.017, OR = 0.652, 95%CI: 0.459-0.926) and elevated preoperative PLR (p = 0.048, OR = 0.996, 95%CI: 0.993-1.000) seemed to be independent protective factors. Larger tumor size did not show significant association with LNM.
Approximately three-quarters of T2 CRC patients are likely to avoid unnecessary surgery. Female, poorly differentiated tumors, perineural invasion, and lymphovascular invasion are expected to be used as predictors of LNM in T2 CRC.
结直肠癌(CRC)是全球消化系统最常见的恶性肿瘤,发病率排名第三,死亡率排名第二。在以往的研究中,T2期结直肠癌的淋巴结转移(LNM)率在18.0%至28.0%之间。我们旨在识别无淋巴结转移的T2期结直肠癌患者,从而减轻手术相关并发症及其对生活质量的潜在影响。
在这项回顾性研究中,选取了787例T2期结直肠癌病例。对术前和术后的临床病理特征进行回顾性研究。采用二元逻辑回归进行单因素分析和多因素分析,以确定淋巴结转移的预测因素。计算比值比(OR)和95%置信区间(CI)。
184例(23.4%)患者被诊断为淋巴结转移,其中144例(78.3%)为N1期患者,40例(21.7%)为N2期患者。根据单因素分析和多因素分析,低分化肿瘤(p = 0.003,OR = 4.405,95%CI:1.632 - 11.893)、神经侵犯(p = 0.001,OR = 4.789,95%CI:1.958 - 11.716)和脉管侵犯(p = 0.001,OR = 2.779,95%CI:1.497 - 5.159)是淋巴结转移的独立危险因素,而男性(p = 0.017,OR = 0.652,95%CI:0.459 - 0.926)和术前血小板与淋巴细胞比值(PLR)升高(p = 0.048,OR = 0.996,95%CI:0.993 - 1.000)似乎是独立保护因素。肿瘤较大与淋巴结转移无显著相关性。
约四分之三的T2期结直肠癌患者可能避免不必要的手术。女性、低分化肿瘤、神经侵犯和脉管侵犯有望作为T2期结直肠癌淋巴结转移的预测指标。